Webinar | October 10, 2019

Facility Intensification And Cost Reduction Using An Integrated Buffer Delivery Platform

Downstream processing of monoclonal antibodies and other recombinant proteins requires large volumes of buffer to maintain pH and conductivity during chromatographic and ultrafiltration operations. A typical process requires more than 5 L of buffer in downstream purification operations for each liter of cell culture processed. The preparation of these buffers requires a large footprint for ‘buffer farms’ with mixing tanks, filtration equipment and storage tanks to meet the continuous demand for buffers for an overall facility. This has been cited as a bottleneck by many manufacturing facilities. The ability to outsource or implement a streamlined buffer preparation step has numerous benefits including reduced capital, labor, floor space, raw materials inventory, facility overhead and QC testing and release. With these benefits come some risks that pharmaceutical manufacturers must address before implementing a new buffer preparation strategy for these critical raw materials that are fundamental to manufacturing. These risks include raw material variability, accuracy of the buffer specifications, as well as stability and quality of the buffer upon transport and over time.

VIEW THE WEBINAR!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of BioProcess Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: